Diet and Exercise for High Blood Pressure
(MAT Trial)
Trial Summary
What is the purpose of this trial?
The goal of this randomized controlled trial is to determine the impact of Mediterranean-Dash Intervention for Neurodegenerative Delay (MIND) diet and aerobic training on cognition in Black adults with high systolic blood pressure. Researchers will compare Food Delivery and Cooking PLUS Aerobic Training (FoRKS+) versus Enhanced Usual Care (EUC) to evaluate the effects on cognition. Participants will complete cognitive and cardiovascular assessments, 24-hr blood pressure monitoring, standard blood pressure measurements, weight, fingerstick for HbA1c point-of-care testing, and questionnaires. Participants may also choose to participate in an optional blood draw for DNA Repair Capacity testing as a modifiable risk factor for aging-associated diseases.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it excludes those who have been prescribed certain medications for cognitive issues. It's best to discuss your specific medications with the trial coordinators.
What data supports the effectiveness of the treatment MIND Foods and Aerobic Training for high blood pressure?
Is the MIND diet safe for humans?
How is the MIND Foods and Aerobic Training treatment different from other treatments for high blood pressure?
The MIND Foods and Aerobic Training treatment is unique because it combines the MIND diet, which is a blend of the Mediterranean and DASH diets, with aerobic exercise to potentially lower blood pressure and improve heart and mental health. This approach is novel as it targets both dietary and physical activity aspects, unlike many treatments that focus solely on medication or diet.124910
Research Team
Daniel O Clark, PhD
Principal Investigator
Indiana University
Eligibility Criteria
This trial is for Black adults aged 35-75 living in Marion County with high blood pressure, who are physically inactive, have stable housing with a kitchen, and can see/read street signs. They must be fluent in English and independent in daily activities. Those with normal cognition scores are eligible.Inclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete cognitive and cardiovascular assessments, blood pressure, weight, HbA1c testing, questionnaires, 24-hour ambulatory blood pressure, and optional blood draw
Treatment
Participants receive either Enhanced Usual Care (EUC) or Food Delivery and Cooking PLUS Aerobic Training (FoRKS+). EUC includes a 5-week Hypertension Self-Management Education and Support (SMES) class. FoRKS+ includes the same SMES class plus 11 weeks of MIND diet ingredient kits and virtual cooking classes, and 12 weeks of aerobic training
Mid-Intervention Assessment
Assessments completed at mid-intervention around Week 16
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at Week 28 and Week 52
Treatment Details
Interventions
- MIND Foods and Aerobic Training (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Indiana University
Lead Sponsor
Alan Palkowitz
Indiana University
Chief Executive Officer since 2020
PhD in Chemistry from Indiana University
David Ingram
Indiana University
Chief Medical Officer since 2020
MD from Indiana University School of Medicine
National Institutes of Health (NIH)
Collaborator
Dr. Jeanne Marrazzo
National Institutes of Health (NIH)
Chief Medical Officer
MD from University of California, Los Angeles
Dr. Jay Bhattacharya
National Institutes of Health (NIH)
Chief Executive Officer
MD, PhD from Stanford University
National Institute on Aging (NIA)
Collaborator
Dr. Richard J. Hodes
National Institute on Aging (NIA)
Chief Executive Officer since 1993
MD from Harvard Medical School
Dr. Marie Bernard
National Institute on Aging (NIA)
Chief Medical Officer
MD from Harvard Medical School